Teva Pharmaceutical Industries Ltd. has announced that the US FDA has granted final approval for the company's ANDA for Paroxetine Hydrochloride Tablets, 10 mg, 20 mg, 30 mg and 40 mg. Shipment of this product is expected to begin immediately.
Teva's Paroxetine HCl Tablets are the AB-rated generic equivalent of GlaxoSmithKline's antidepressant Paxil Tablets.